News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
40 Under 40
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
542,300 Results
Type
Article (34165)
Company Profile (163)
Press Release (507972)
Multimedia
Podcasts (53)
Webinars (10)
Section
Business (155518)
Career Advice (886)
Deals (25348)
Drug Delivery (71)
Drug Development (59756)
Employer Resources (88)
FDA (14274)
Job Trends (11965)
News (260462)
Policy (24229)
Tag
Academia (2321)
Accelerated approval (4)
Adcomms (8)
Allergies (85)
Alliances (43646)
ALS (67)
Alzheimer's disease (1037)
Antibody-drug conjugate (ADC) (97)
Approvals (14329)
Artificial intelligence (264)
Autoimmune disease (15)
Automation (13)
Bankruptcy (212)
Best Places to Work (9790)
BIOSECURE Act (10)
Biosimilars (44)
Biotechnology (120)
Bladder cancer (63)
Brain cancer (23)
Breast cancer (227)
Cancer (1808)
Cardiovascular disease (138)
Career advice (782)
Career pathing (18)
CAR-T (134)
Cell therapy (350)
Cervical cancer (19)
Clinical research (49146)
Collaboration (751)
Compensation (212)
Complete response letters (11)
COVID-19 (2012)
CRISPR (41)
C-suite (209)
Cystic fibrosis (75)
Data (1834)
Decentralized trials (2)
Denatured (26)
Depression (34)
Diabetes (213)
Diagnostics (5847)
Digital health (17)
Diversity (7)
Diversity, equity & inclusion (19)
Drug discovery (102)
Drug pricing (63)
Drug shortages (23)
Duchenne muscular dystrophy (64)
Earnings (55092)
Editorial (22)
Employer branding (12)
Employer resources (78)
Events (77439)
Executive appointments (607)
FDA (15413)
Fibrodysplasia Ossificans Progressiva (1)
Friedreich's ataxia (3)
Frontotemporal dementia (3)
Funding (615)
Gene editing (97)
Generative AI (25)
Gene therapy (232)
GLP-1 (519)
Government (3481)
Grass and pollen (4)
Guidances (53)
Healthcare (15647)
Huntington's disease (12)
IgA nephropathy (22)
Immunology and inflammation (55)
Indications (24)
Infectious disease (2122)
Inflammatory bowel disease (107)
Inflation Reduction Act (5)
Influenza (43)
Intellectual property (81)
Interviews (114)
IPO (10978)
IRA (23)
Job creations (2585)
Job search strategy (683)
Kidney cancer (8)
Labor market (17)
Layoffs (249)
Leadership (7)
Legal (4967)
Liver cancer (63)
Lung cancer (264)
Lymphoma (119)
Machine learning (6)
Management (34)
Manufacturing (222)
MASH (55)
Medical device (14058)
Medtech (14063)
Mergers & acquisitions (14799)
Metabolic disorders (522)
Multiple sclerosis (62)
NASH (12)
Neurodegenerative disease (64)
Neuropsychiatric disorders (12)
Neuroscience (1439)
NextGen: Class of 2025 (5440)
Non-profit (3479)
Now hiring (22)
Obesity (254)
Opinion (135)
Ovarian cancer (64)
Pain (80)
Pancreatic cancer (66)
Parkinson's disease (113)
Partnered (17)
Patents (192)
Patient recruitment (96)
Peanut (47)
People (47822)
Pharmaceutical (32)
Pharmacy benefit managers (11)
Phase I (15207)
Phase II (21465)
Phase III (16581)
Pipeline (915)
Policy (78)
Postmarket research (1809)
Preclinical (5947)
Press Release (67)
Prostate cancer (87)
Psychedelics (18)
Radiopharmaceuticals (213)
Rare diseases (256)
Real estate (4652)
Recruiting (34)
Regulatory (17471)
Reports (19)
Research institute (2103)
Resumes & cover letters (136)
Rett syndrome (5)
RNA editing (2)
RSV (33)
Schizophrenia (55)
Series A (106)
Series B (69)
Service/supplier (8)
Sickle cell disease (32)
Special edition (4)
Spinal muscular atrophy (118)
Sponsored (22)
Startups (3221)
State (2)
Stomach cancer (9)
Supply chain (49)
Tariffs (14)
The Weekly (26)
Vaccines (534)
Venture capitalists (26)
Weight loss (164)
Women's health (25)
Worklife (6)
Date
Today (90)
Last 7 days (661)
Last 30 days (1981)
Last 365 days (25674)
2025 (8285)
2024 (27804)
2023 (31988)
2022 (42421)
2021 (45899)
2020 (44737)
2019 (39311)
2018 (29957)
2017 (26893)
2016 (25855)
2015 (30142)
2014 (22891)
2013 (19279)
2012 (20849)
2011 (21337)
2010 (19678)
Location
Africa (534)
Alabama (47)
Alaska (6)
Arizona (177)
Arkansas (13)
Asia (33918)
Australia (5752)
California (4495)
Canada (1669)
China (458)
Colorado (210)
Connecticut (233)
Delaware (129)
Europe (71804)
Florida (744)
Georgia (180)
Idaho (50)
Illinois (441)
India (19)
Indiana (260)
Iowa (7)
Japan (157)
Kansas (101)
Kentucky (16)
Louisiana (7)
Maine (33)
Maryland (766)
Massachusetts (3166)
Michigan (224)
Minnesota (325)
Mississippi (2)
Missouri (75)
Montana (27)
Nebraska (23)
Nevada (41)
New Hampshire (67)
New Jersey (1424)
New Mexico (20)
New York (1322)
North Carolina (788)
North Dakota (9)
Northern California (1889)
Ohio (176)
Oklahoma (11)
Oregon (31)
Pennsylvania (1021)
Puerto Rico (12)
Rhode Island (30)
South America (792)
South Carolina (24)
South Dakota (1)
Southern California (1727)
Tennessee (85)
Texas (702)
United States (17777)
Utah (161)
Virginia (104)
Washington D.C. (43)
Washington State (451)
West Virginia (3)
Wisconsin (54)
542,300 Results for "creative medical technology".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Creative Medical Technology Holdings Expands Collaboration with Greenstone Biosciences to Accelerate iPSCelz Pipeline Development
February 5, 2025
·
3 min read
Press Releases
Creative Medical Technology Reports Positive One-Year Results for AlloStem™ Type 2 Diabetes Program
February 12, 2025
·
3 min read
Press Releases
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
March 20, 2025
·
3 min read
BioMidwest
Creative Medical Technology Holdings Announces Evolutionary Development of its iPSCelz® Program with the Successful Generation of iPSC Derived Islet Cells that Produce Human Insulin
Creative Medical Technology Holdings, Inc. announced that it has successfully generated human induced pluripotent stem cells -derived Islet Cells that produce human insulin.
June 24, 2024
·
3 min read
Policy
Creative Medical Technology Holdings, Inc. Receives FDA Orphan Drug Designation for CELZ-101 in Key Transplantation Therapy
Creative Medical Technology Holdings, Inc. is pleased to announce the successful receipt of Orphan Drug Designation from the U.S. Food and Drug Administration for CELZ-101, ImmCelzTM.
March 6, 2024
·
4 min read
Press Releases
Creative Medical Technology Holdings Announces Mid-Term Follow-up Study Data Reporting Significant Reduction in Opioid Use by Chronic Lower Back Pain Patients Undergoing StemSpine® Procedure using AlloStem™
February 14, 2025
·
3 min read
Press Releases
Creative Medical Technology Holdings Announces Positive Initial Safety, Tolerability, and Efficacy Data from First Cohort in Phase 1/2 Trial of CELZ-201-DDT for Chronic Back Pain
January 30, 2025
·
3 min read
Press Releases
Creative Medical Technology Holdings Announces $1.85 Million Registered Direct Offering Priced At-The-Market Under Nasdaq Rules
October 24, 2024
·
3 min read
Press Releases
Creative Proteomics Unveils Cutting-Edge N-terminal Edman Degradation Service for Advanced Protein Sequencing
March 25, 2025
·
1 min read
Creative Biolabs: The Antibody Landscape Is Revolving
As the industry witnesses a surge in demand for innovative antibodies on prevalent research targets, Creative Biolabs is poised to meet and exceed these expectations with their comprehensive suite of services.
June 5, 2024
·
3 min read
1 of 54,230
Next
